After several years of extensive studies, Maitake Products, Inc. has announced a new product based on the newly discovered active fraction of Maitake,
Grifron SX-fraction. Studies have been conducted at Georgetown University and NY Medical College, with results showing SX-Fraction to posses a potent ability to
support maintenance of healthy blood sugar levels.
Grifron, SX-Fraction, the only standardized extract to contain the active SX-fraction, is launched as the first dietary supplement of its class that specifically addresses its beneficial role in Syndrome X as a part of a diet to help maintain healthy blood sugar and blood pressure levels. (This sinister-sounding syndrome; also known as Insulin Resistance Syndrome, Metabolic Syndrome, Fat Gut Syndrome or Deadly Quartet; is a cluster of symptoms that may include the following:
- obesity (excessive fat tissue in the abdominal region)
- hyperlipidemia (high triglycerides and low HDL cholesterol)
- high blood pressure
- glucose intolerance (higher blood glucose level than normal)
Syndrome X can lead to life-threatening diseases including type II diabetes, hypertension and heart disease. More importantly, people with Syndrome X are also more likely than others to die from cardiovascular disease. It is said that 50~70 million Americans are supposed to have Syndrome X, and most of whom are unaware of this serious problem.
Suggested Usage:
For general support for healthy blood sugar maintenance, take one tablet within 30 minutes after each meal.One tablets three times a day. For maximum impact, you may double or triple the general dose.
Ingredients: Every one tablet contains 100mg of Maitake standardized extract (SX-fraction 18%) and 250 mg of Maitake fruit body powder. It contains NO sugar, yeast, mold, artificial colors, dairy foods, chemical pesticides or fertilizers.
SX-Fraction is a trademark applied for registration by Maitake Products, Inc. "SX" stands for both "Syndrome X" and "Super X", since SX-fraction is developed as an improved version of X-fraction which is also patented by Maitake Products, Inc. (U.S. Patent #5,773,426).